Search details
1.
Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
Cancer
; 129(16): 2581-2592, 2023 08 15.
Article
in English
| MEDLINE | ID: mdl-37096763
2.
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
Oncology
; 101(6): 349-357, 2023.
Article
in English
| MEDLINE | ID: mdl-36273439
3.
Total neoadjuvant therapy approach for the treatment of locally advanced rectal cancer. Where do we stand?
Oncology
; 2023 Nov 07.
Article
in English
| MEDLINE | ID: mdl-37935161
4.
SARS-CoV-2 Virus in Cancer Patients: A New Unknown in an Unsolved Equation.
Oncology
; 101(1): 1-11, 2023.
Article
in English
| MEDLINE | ID: mdl-36063800
5.
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer.
World J Urol
; 41(12): 3829-3838, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37966505
6.
Stereotactic body radiation therapy for kidney cancer. Where do we stand?
Int J Urol
; 30(5): 437-445, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36746747
7.
Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma.
Rep Pract Oncol Radiother
; 27(3): 500-508, 2022.
Article
in English
| MEDLINE | ID: mdl-36186695
8.
Metformin and statins: a possible role in high-risk prostate cancer.
Rep Pract Oncol Radiother
; 25(2): 163-167, 2020.
Article
in English
| MEDLINE | ID: mdl-32021570
9.
Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study.
BMC Cancer
; 19(1): 1163, 2019 Nov 29.
Article
in English
| MEDLINE | ID: mdl-31783816
10.
Nanoparticles applied to cancer immunoregulation.
Rep Pract Oncol Radiother
; 24(1): 47-55, 2019.
Article
in English
| MEDLINE | ID: mdl-30425606
11.
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study).
Br J Cancer
; 119(9): 1052-1059, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30131546
12.
Management of lateral pelvic lymph nodes in rectal cancer: Is it time to reach an Agreement?
World J Clin Oncol
; 15(4): 472-477, 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38689627
13.
Liquid biopsy to personalize treatment for metastatic prostate cancer.
Am J Transl Res
; 16(5): 1531-1549, 2024.
Article
in English
| MEDLINE | ID: mdl-38883349
14.
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
Clin Genitourin Cancer
; 22(1): 56-66, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37599133
15.
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain.
Cancers (Basel)
; 16(9)2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38730637
16.
A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532).
Eur Urol Oncol
; 2024 Jan 24.
Article
in English
| MEDLINE | ID: mdl-38272747
17.
Radiotherapy for Metastatic Epidural Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial.
Cancers (Basel)
; 16(6)2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-38539484
18.
Novel Approaches in the Systemic Management of High-Risk Prostate Cancer.
Clin Genitourin Cancer
; 21(6): e485-e494, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37453915
19.
Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?
Clin Genitourin Cancer
; 21(3): e93-e103, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36456467
20.
Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer.
Clin Transl Oncol
; 25(4): 897-911, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36525230